Document is current
Any future updates will be listed below
-
Authors
Lösslein, Anne Kathrin https://orcid.org/0000-0002-0570-5902
Goerne, Tessa https://orcid.org/0000-0001-5885-6029
Elling, Roland https://orcid.org/0000-0002-2209-4154
Wengenmayer, Tobias https://orcid.org/0000-0002-3659-0407
Häcker, Georg https://orcid.org/0000-0003-1058-5746
Biever, Paul Marc https://orcid.org/0000-0002-3470-5936
-
Funding
Funding for this research was provided by:
Universitätsklinikum Freiburg
- License Information
-
More Information
Article History
Received: 3 August 2025
Accepted: 10 October 2025
First Online: 31 October 2025
Declarations
:
: The research project was approved by the Ethics Committee of the University of Freiburg (24-1116-S1-retro and 24-1116_1-S1-retro) on 21st May 2024 and 11th February 2025. The retrospective study was registered in the German Clinical Trials Register (DRKS00033853) and the International Clinical Trials Registry Platform of the WHO.
: Patient consent was waived after approval by the ethics committee.
: The authors declare no conflicts of interest. TW received honoraria for presentations from AstraZeneca, Boston Scientific, Abbott Medical.
